Market Place
Sourcing Support
Lupin Launches Generic Anti-Diabetic Tablets In US
22 Apr 2026 //
ECONOMICTIMES
Lupin Launches Dapagliflozin Tablets In The United States
10 Apr 2026 //
PR NEWSWIRE
Lupin Gets ANDA Approval For Dapagliflozin, Metformin Er Tablets
09 Apr 2026 //
EXPRESSPHARMA
Lupin Gets FDA Approval For Dapagliflozin Tablets In US
07 Apr 2026 //
PR NEWSWIRE
Lupin Gets Tentative FDA Nod For Sugammadex Injection
31 Mar 2026 //
PR NEWSWIRE
Lupin Gets Tentative FDA Approval for Pitolisant Tablets
25 Mar 2026 //
PR NEWSWIRE
Lupin Launches Brivaracetam Oral Solution In US
25 Feb 2026 //
PRESS RELEASE
Lupin Secures EC Approval for Ranluspec, Ranibizumab Biosimilar
23 Feb 2026 //
PRESS RELEASE
Lupin Introduces Topiramate Extended-Release Capsules In US
05 Feb 2026 //
PRESS RELEASE
Lupin Launches Dasatinib Tablets In The United States
02 Feb 2026 //
PRESS RELEASE
Lupin Receives Tentative U.S. FDA Approval For Siponimod Tablets
05 Dec 2025 //
PRESS RELEASE
Neuland, Lupin, Divi`s Lead CDMO Surge Amid U.S. Generics Woes
25 Nov 2025 //
BUSINESS STD
Lupin Launches Long-Acting Risperidone In US
15 Nov 2025 //
PRESS RELEASE
Lupin Launches Authorized Generic Of Ravicti In US
24 Oct 2025 //
INDPHARMAPOST
Gilead Inks Biktarvy Settlements With 3 Generic Drug Makers
07 Oct 2025 //
FIERCE PHARMA
Lupin Launches Liraglutide Injection In US
04 Oct 2025 //
INDPHARMAPOST
Lupin Gets FDA Nod For Rivaroxaban Oral Suspension
30 Sep 2025 //
EXPRESSPHARMA
Lupin Gets Tentative FDA Nod For Biktarvy Tablets
25 Sep 2025 //
EXPRESSPHARMA
Indian Pharma Prepares For ?600-800 Cr Insulin Pen Market
22 Sep 2025 //
BUSINESS STD
FDA approves Lupin`s Lenalidomide capsules
17 Sep 2025 //
INDPHARMAPOST
Lupin Gets FDA Nod for Risperidone Long-Acting Injectable
10 Sep 2025 //
PRESS RELEASE
Lupin Receives USFDA Approval for Generic Risperidone Injectable
05 Sep 2025 //
ECONOMICTIMES
Catalyst Pharma Settles Firdapse Patent Dispute with Lupin
25 Aug 2025 //
GLOBENEWSWIRE
Lupin Releases Glucagon Injection USP in the US
11 Aug 2025 //
EXPRESSPHARMA
Lupin Wins US FDA Approvals for Liraglutide and Glucagon
26 Jul 2025 //
EXPRESSPHARMA
Lupin launches Loteprednol Etabonate Ophthalmic Suspension in US
17 Jul 2025 //
EXPRESS PHARMA
Lupin Gets FDA nod for Loteprednol Etabonate Ophthalmic Gel
03 Jul 2025 //
EXPRESSPHARMA
Lupin receives USFDA approval for Prucalopride Tablets
26 Jun 2025 //
INDPHARMAPOST
Lupin Launches Prucalopride Tablets in U.S.
26 Jun 2025 //
EXPRESSPHARMA
Lupin Gets Tentative US FDA Nod for Oxcarbazepine Tablet
09 Jun 2025 //
EXPRESSPHARMA
Harmony Biosciences Strengthens Patent Position with Settlement
05 Jun 2025 //
BUSINESSWIRE
Girard Sharp and Motley Rice Announce Proposed Settlement
27 May 2025 //
PR NEWSWIRE
Lupin receives USFDA approval for Rivaroxaban Tablets
19 May 2025 //
INDPHARMAPOST
Lupin to boost complex generics in US, EU; eyes India growth
19 May 2025 //
BUSINESS STD
Lupin launches Tolvaptan Tablets in the US
14 May 2025 //
EXPRESS PHARMA
Lupin gains USFDA nod for Raltegravir Tablets USP, 600 mg
09 May 2025 //
EXPRESSPHARMA
Lupin Launches Eslicarbazepine Acetate Tablets in Us
08 May 2025 //
INDPHARMAPOST
Lupin receives US FDA approval for generic Tolvaptan Tablets
25 Apr 2025 //
EXPRESSPHARMA
Lupin receives approval from FDA for Ipratropium Br Nasal Solution
11 Feb 2025 //
INDPHARMAPOST
Lupin receives tentative FDA approval for generic Darunavir
06 Feb 2025 //
EXPRESS PHARMA
Lupin gets USFDA nod for generic HIV drug
24 Jan 2025 //
ECONOMICTIMES
Lupin launches Minzoya in the US
14 Jan 2025 //
PRESS RELEASE
Lupin Gets Tentative U.S. FDA Approval For Ivacaftor Oral Granules
10 Jan 2025 //
EXPRESSPHARMA
Lupin receives FDA tentative approval for HIV treatment generic
07 Dec 2024 //
EXPRESSPHARMA
FDA gives tentative approval to Lupin’s for treat type 2 diabetes
30 Nov 2024 //
FINANCIALXPRESS
Lupin receives FDA approval for generic version of Adderall XR
21 Nov 2024 //
EXPRESSPHARMA
Lupin launches Bumetanide Injection USP in US
20 Nov 2024 //
PRESS RELEASE
Lupin receives tentative FDA approval for Raltegravir tablets
11 Nov 2024 //
EXPRESSPHARMA
Lupin launches first generic of Pred Forte in the US
16 Oct 2024 //
EXPRESSPHARMA
Lupin gets US FDA nod for Bumetanide Injection, USP
19 Sep 2024 //
EXPRESSPHARMA
Lupin receives U.S. FDA approval for Brimonidine Tartrate Ophthalmic Solution
28 Aug 2024 //
EXPRESSPHARMA
Lupin receives USFDA approval for Prednisolone Acetate Ophthalmic Suspension USP
06 Aug 2024 //
INDPHARMAPOST
Lupin receives US FDA tentative marketing approval for generic Descovy tablets
31 Jul 2024 //
PHARMABIZ
Generic HIV raltegravir medicines approved
22 Jul 2024 //
EUROPEAN PHARMACEUTICAL REVIEW
Lupin receives FDA tentative marketing approval for generic Trijardy XR tablets
09 Jul 2024 //
PHARMABIZ
Astellas’ generic Myrbetriq defence knocked back again
20 Apr 2024 //
PHARMAPHORUM
Lupin Receives Approval from FDA for Aripiprazole Tablets, USP
19 Mar 2024 //
PRESS RELEASE
Lupin gets USFDA nod for generic hypertension drug
14 Jan 2024 //
HEALTH ET
Lupin introduces generic product in US market
10 Jan 2024 //
ECONOMIC TIMES
Lupin gets USFDA nod to market generic antifungal tablets
25 Oct 2023 //
ECONOMIC TIMES
